Literature DB >> 9276625

Effect of naturally occurring coumarins on the formation of epidermal DNA adducts and skin tumors induced by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in SENCAR mice.

Y Cai1, H Kleiner, D Johnston, A Dubowski, S Bostic, W Ivie, J DiGiovanni.   

Abstract

Several naturally occurring coumarins previously found to be potent inhibitors of mouse hepatic ethoxyresorufin-O-deethylase (EROD) and/or pentoxyresorufin-O-dealkylase (PROD) were examined for their effects on formation of benzo[a]pyrene (B[a]P) and 7,12-dimethylbenz[a]anthracene (DMBA) DNA adducts in mouse epidermis, as well as, their effects on skin tumor initiation by these polycyclic aromatic hydrocarbons (PAH). Bergamottin, a potent inhibitor of hepatic EROD, given topically 5 min prior to an initiating dose of B[a]P, significantly decreased total covalent binding of B[a]P to DNA in a dose-dependent manner 24 h after treatment. A dose of 400 nmol bergamottin reduced covalent binding of B[a]P by 72%. Coriandrin, at a dose of 400 nmol also significantly reduced total covalent binding of B[a]P by 59%. In addition, formation of the major (+)anti-B[a]P-diol epoxide-N2-dGuo adduct was selectively reduced by both of these coumarins. In contrast, bergamottin and coriandrin did not significantly decrease covalent binding of DMBA to epidermal DNA at doses of either 400 nmol or 800 nmol. Imperatorin and isopimpinellin, which are more potent inhibitors of hepatic PROD activity, significantly reduced overall binding of DMBA to epidermal DNA by 67% and 52%, respectively, when applied at doses of 400 nmol. These two coumarins also inhibited B[a]P-DNA adduct formation at similar doses but to a lesser extent. Imperatorin at a dose of 400 nmol dramatically decreased formation of covalent DNA adducts derived from both the anti and syn diol epoxides of DMBA. Bergamottin was a potent inhibitor of tumor initiation by B[a]P while coriandrin was less effective in this regard. Imperatorin was an effective inhibitor of skin tumor initiation by DMBA and also inhibited complete carcinogenesis by this PAH. At dose levels higher than those effective against DMBA, imperatorin also inhibited tumor initiation by B[a]P. The results demonstrate that several naturally occurring coumarins possess the ability to block DNA adduct formation and tumor initiation by PAHs such as B[a]P and DMBA. The mechanism for reduced DNA adduct formation and tumor initiation appears to involve inhibition of the P450s involved in the metabolic activation of these hydrocarbons. Finally, the differential effects of certain coumarins on B[a]P vs DMBA DNA adduct formation and tumor initiation may be useful for dissecting the role of specific cytochromes P450 in their metabolic activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276625     DOI: 10.1093/carcin/18.8.1521

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  Effects of naturally occurring coumarins on hepatic drug-metabolizing enzymes in mice.

Authors:  Heather E Kleiner; Xiaojun Xia; Junichiro Sonoda; Jun Zhang; Elizabeth Pontius; Jane Abey; Ronald M Evans; David D Moore; John DiGiovanni
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-15       Impact factor: 4.219

2.  The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors.

Authors:  Inok Surh; Joyce E Rundhaug; Amy Pavone; Carol Mikulec; Erika Abel; Melissa Simper; Susan M Fischer
Journal:  Mol Carcinog       Date:  2011-07-07       Impact factor: 4.784

Review 3.  Effects of psoralens as anti-tumoral agents in breast cancer cells.

Authors:  Maria Luisa Panno; Francesca Giordano
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Glaucarubulone glucoside from Castela macrophylla suppresses MCF-7 breast cancer cell growth and attenuates benzo[a]pyrene-mediated CYP1A gene induction.

Authors:  Simone A M Badal; Malyn M Asuncion Valenzuela; Dain Zylstra; George Huang; Pallavi Vendantam; Sheena Francis; Ashley Quitugua; Louisa H Amis; Willie Davis; Tzuen-Rong J Tzeng; Helen Jacobs; David J Gangemi; Greg Raner; Leah Rowland; Jonathan Wooten; Petreena Campbell; Eileen Brantley; Rupika Delgoda
Journal:  J Appl Toxicol       Date:  2017-01-31       Impact factor: 3.446

Review 5.  A review of coumarin derivatives in pharmacotherapy of breast cancer.

Authors:  Musiliyu A Musa; John S Cooperwood; M Omar F Khan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 6.  Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest.

Authors:  Renato Bruni; Davide Barreca; Michele Protti; Virginia Brighenti; Laura Righetti; Lisa Anceschi; Laura Mercolini; Stefania Benvenuti; Giuseppe Gattuso; Federica Pellati
Journal:  Molecules       Date:  2019-06-08       Impact factor: 4.411

7.  Suppressive Effects of Selected Food Phytochemicals on CD74 Expression in NCI-N87 Gastric Carcinoma Cells.

Authors:  Hirotaka Sekiguchi; Kazuto Washida; Akira Murakami
Journal:  J Clin Biochem Nutr       Date:  2008-09       Impact factor: 3.114

8.  Assessment of the genotoxic/clastogenic potential of coumarin derivative 6,7-dihydroxycoumarin (aesculetin) in multiple mouse organs.

Authors:  Eduardo de Souza Marques; Daiane Bernardoni Salles; Edson Luis Maistro
Journal:  Toxicol Rep       Date:  2015-01-27

Review 9.  Chemistry and health effects of furanocoumarins in grapefruit.

Authors:  Wei-Lun Hung; Joon Hyuk Suh; Yu Wang
Journal:  J Food Drug Anal       Date:  2016-12-06       Impact factor: 6.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.